Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NMR-derived model for a peptide-antibody complex.

B Zilber1, T Scherf, M Levitt

  • 1Department of Polymer Research, Weizmann Institute of Science, Rehovot, Israel.

Biochemistry
|October 30, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-prostatectomy adjuvant androgen deprivation therapy- Current opinions and practices of Canadian urologists.

Urologic oncology·2021
Same author

Preserving Access: A Review of Stroke Thrombectomy during the COVID-19 Pandemic.

AJNR. American journal of neuroradiology·2020
Same author

A tailored surgical approach to the palpable undescended testis.

Journal of pediatric urology·2018
Same author

Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung disease.

Pediatric surgery international·2017
Same author

Finite-difference solution of the Poisson-Boltzmann equation: Complete elimination of self-energy.

Journal of computational chemistry·2014
Same author

Propranolol as first-line treatment in orbital infantile haemangiomas: a case series.

Orbit (Amsterdam, Netherlands)·2014

The TE34 antibody, despite sharing homology with toxin-binding antibodies, does not bind cholera toxin due to a unique binding site structure. This study reveals the structural basis for this lack of binding, offering insights into antibody-antigen interactions.

Area of Science:

  • Immunology
  • Structural Biology
  • Biochemistry

Background:

  • Monoclonal antibodies are crucial tools in immunology and diagnostics.
  • Understanding antibody-antigen interactions at a molecular level is key to developing targeted therapies.

Purpose of the Study:

  • To elucidate the structural basis for the lack of binding of the TE34 monoclonal antibody to cholera toxin peptide 3 (CTP3).
  • To characterize the molecular interactions within the TE34 antibody's combining site.

Main Methods:

  • Sequencing of the TE34 monoclonal antibody.
  • Two-dimensional transferred NOE difference spectroscopy.
  • Molecular modeling and computational analysis.
  • Use of truncated peptide analogs and isotopically labeled antibodies.

Related Experiment Videos

Main Results:

  • TE34 shares high sequence homology with anti-CTP3 antibodies TE32 and TE33 but does not bind cholera toxin.
  • A shortened heavy chain CDR3 in TE34 results in a distinct combining site structure.
  • The TE34 combining site is a hydrophobic cavity with peripheral charged residues.
  • The peptide residues HIDSQKKA form a beta-turn within the binding site.
  • The antibody-peptide contact area is approximately 388 A2, significantly smaller than typical protein-antibody complexes.

Conclusions:

  • The structural differences in the combining site, particularly the shortened CDR3, explain TE34's inability to bind cholera toxin.
  • The study provides a detailed 3D model of the TE34/CTP3 complex, highlighting specific molecular interactions.
  • Findings contribute to the understanding of antibody specificity and the structural determinants of antigen binding.